alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
EXHIBIT 31.1
                                  CERTIFICATION

        I, Bernard Berk, certify that:

        1.      I have  reviewed  this  quarterly  report  on Form 10-Q of Elite
                Pharmaceuticals, Inc. (the "registrant");

        2.      Based on my  knowledge,  this report does not contain any untrue
                statement  of a material  fact or omit to state a material  fact
                necessary  to  make  the  statements   made,  in  light  of  the
                circumstances   under  which  such  statements  were  made,  not
                misleading with respect to the period covered by this report;

        3.      Based on my  knowledge,  the  financial  statements,  and  other
                financial information included in this report, fairly present in
                all  material  respects  the  financial  condition,  results  of
                operations  and cash flows of the registrant as of, and for, the
                periods presented in this report;

        4.      The registrant's  other certifying officer and I are responsible
                for  establishing  and  maintaining   disclosure   controls  and
                procedures  (as  defined in  Exchange  Act Rules  13a-15(e)  and
                15d-15(e)) for the registrant and have designed such  disclosure
                controls and procedures,  or caused such disclosure controls and
                procedures to be designed under our supervision,  to ensure that
                material information  relating to the registrant,  including its
                consolidated subsidiaries,  is made known to us by others within
                those  entities,  particularly  during  the period in which this
                report is being prepared.



                                    /s/ Bernard Berk
Date:  February 11, 2005            -------------------------------------
                                    Bernard Berk
                                    Chief Executive Officer
Complainants, 

v. Docket No. 16-16-02 

CITY OF SANTA MONICA, CALIFORNIA, 

Respondent. 

NOTICE OF CHANGE OF FIRM ADDRESS 

Please take notice that Scott P. Lewis, DavidS. Mackey, Jessica A. Wall, and the finn 

Anderson & Kreiger LLP, counsel for City of Santa Monica, Califomia, have changed their 

address effective October 1, 2016 to: 

ANDERSON & KREIGER LLP 

50 Milk Street, 21st Floor 

Boston, MA 021 09 

Sc tt . Lewis 

Dav1a S. Mackey 

Jessica A. Wall 

ANDERSON & KREIGER LLP 

1 Canal Park, Suite 200 

Cambridge, MA 02141 

617.621.6560 

slewis@andersonkreiger. com 

--
1685 Main Street, Room 310 

Santa Monica, CA 90401 

310.458.8233 

Marsha.Moutrie@smgov .net 

CERTIFICATE OF SERVICE 

I hereby certify in accordance with 14 C.F.R. § 16.13 that I have on this day served the 

foregoing Notice of Firm Address Change on the following persons at the following addresses by 

email and first class mail: 

FAA Part 16 Docket Clerk 

AGC-600 

Federal Aviation Administration 

800 Independence Avenue, SW 

Washington, D.C. 20591 

9-A WA-AGC-Pmi- 6@faa.gov 

September 27, 2016 

.. · 

... ..--

Richard K. Simon 

1700 Decker School Lane 

Malibu, CA 90265 

310-503-7286 

rsimon3 @verizon.net
November 17, 2015

FAA UAS Integration Office, 

800 Independence Ave. SW.

Washington DC 20591

To whom it concerns,

CORRECTION: Petition for Exemption from Certain Federal Aviation Regulations, Pursuant to Section 

333 of the FAA Modernization and Reform Act of 2012. Notification of Error in Submitted Document 

Pursuant to Regulaitons.gov Section 333 Exemption Comment: 1jz-8lou-9bcw

After I submitted my application for an exemption, an independent review of my document was 

completed and it was highlighted that an error was made in an attempt to simplify the list of regulations 

from which an exemption is requested. On pages 8 and 21, no mention is made of 14 C.F.R. §91.215 

ATC transponder and altitude reporting equipment and use.

Please ensure that this particular regulation is included in the list of exempted regulations.

This error in categorical simplification does not change the nature of the document or cause the document 

to fail to meet any requirement set forth in the Petition Guidelines located at the following address:

http://aes.faa.gov/Petition/

Therefore, when my request is formally reviewed and processed, this document should also be utilized to 

complement my submitted exemption that was submitted to Regulations.gov since the reasoning for relief 

was (with the exception of this minor detail) properly requested within the original document. If you have 

any questions, please feel free to contact me.

Thank you,

Eric Swanson

(708) 653-6564

support@cardinaluav.com
----

**CERTIFICATION PURSUANT TO SECTION 302 OF THE SARBANES OXLEY  ACT**

I, Abbas Salih, certify that:

 1.      I have reviewed this annual report on Form  10-KSB of Strategic Internet Investments Incorporated; 

 2.      Based on my knowledge, this annual report  does not contain any untrue statement of a material fact or omit to state a  material fact necessary to make the statements made, in light of the circumstances  under which such statements were made, not misleading with respect to the period  covered by this annual report; 

 3.      Based on my knowledge, the financial statements,  and other financial information included in this annual report, fairly present  in all material respects the financial condition, results of operations and  cash flows of the registrant as of, and for, the periods presented in this annual  report; 

 4.      The registrant's other certifying officers  and I are responsible for establishing and maintaining disclosure controls and  procedures (as defined in Exchange Act Rules 13a-14 and 15d-14) for the registrant  and have: 

 a)      designed such disclosure controls and procedures  to ensure that material information relating to the registrant, including its  consolidated subsidiaries, is made known to us by others within those entities,  particularly during the period in which this annual report is being prepared;

 b)      evaluated the effectiveness of the registrant's  disclosure controls and procedures as of a date within 90 days prior to the  filing date of this annual report (the "Evaluation Date"); and 

 c)      presented in this annual report our conclusions  about the effectiveness of the disclosure controls and procedures based on our  evaluation as of the Evaluation Date; 

 5.      The registrant's other certifying officers  and I have disclosed, based on our most recent evaluation, to the registrant's  auditors and the audit committee of registrant's board of directors (or persons  performing the equivalent functions): 

 a)      all significant deficiencies in the design  or operation of internal controls which could adversely affect the registrant's  ability to record, process, summarize and report financial data and have identified  for the registrant's auditors any material weaknesses in internal controls;  and 

 b)      any fraud, whether or not material, that  involves management or other employees who have a significant role in the registrant's  internal controls; and 

 6.      The registrant's other certifying officers  and I have indicated in this annual report whether there were significant changes  in internal controls or in other factors that could significantly affect internal  controls subsequent to the date of our most recent evaluation, including any  corrective actions with regard to significant deficiencies and material weaknesses.

Date: April 13, 2004

 Signed:*/s/ Abbas Salih*                 Abbas Salih 

----
Chemours 

February 15, 2016 

f\ECEIVEO 

0PPT CBIC 

2016 FEB 22 PM 12: 23 

Certified Mail - Retum Receipt Requested 

70150640000596575374 

The Chemours Company 

Fluoroproducts 

67 Canal Road, P. 0. Box 9001 

Chambers Works M Pedersen Building 

Deepwater, NJ 08023 

CBIC Control Number 

368213 

Director, Chemical Control Division 

US Environmental Protection Agency 

Office of Pollution Prevention and Toxics 

EPA East 

RECEIVED 

Ml-\1 0 3 2016 

Room 4146 

1201 Constitution Avenue, NW 

Washington, DC 20004 

RE: EPA- HQ - OPPT - 2003 - 0012 

EPA DOCKET CENTER 

Chemours Chambers Works NJPDES Permit No. NJOOOSlOO 

PFOA Data Submittal- Outfall DSN662 Weekly Grab Samples 

January 2016 Sample Data 

Dear Chemical Control Division: 

Attached please find summaries of PFOA analytical results for the Chemours 

Chambers Works weekly grab samples taken at internal outfall DSN662A in January 

2016. 

In accordance with the current site NJPDES pe1mit (NJ0005100, effective September 

2011), these results are provided to NJDEP on a monthly basis via electronic 

discharge monitoring reports. The enclosures include two paper and two electronic 

copies of the analytical results from this monitoring period. 

NJDEP asked The Chemours Company FC, LLC to analyze for and report monthly 

Spot 662 PFNA concentrations for 12 months. The seventh of the requested 12 

samples is reported in the attached table. 

Si~ 

AmuZ.eyarajasingam 

Area Manager - Secure Environmental Treatment 

Chemours Chambers Works 

AJ/clc 

Enclosures 
Copy to: 

Document Control Office 

US Environmental Protection Agency 

Office of Pollution Prevention and Toxics 

EPA East 

Room6428 

1200 Pennsylvania Avenue, NW 

Washington, DC 20460 

70150640000596575367 

Ms. Heather Genievich (cover letter only) 

NJDEP Division of Water Quality 

Bureau of Surface Water Permitting 

Mail Code 401-02B 

401 E. State Street 

P.O. Box420 

Trenton, NJ 08625-0420 

70150640000596575398 
Sample ID 

Date 

Top (ft) 

Total (T)/ Bottom (ft) 

Analyte units Diss. (D) Duplicate# 

PFOA ug/L T 

PFNA ug/L T 

<and ND= Non detect at stated reporting limit 

Summary of Analytical Results 

662 - January 2016 

662-GRAB 662-GRAB 662-GRAB 

1/4/16 1/11/16 1/18/16 

o o o 

o o o 

1 1 1 

3.12 3.02 2.67 

NA NA 0.173 

PFNA - Perfluorononanoic Acid 

PFOA - Perfluorooctanoic Acid 

ug/L - micrograms per Liter 

I 

662-GRAB 

1/25/16 

0 

o 

1 

3.03 

NA 

ug/L - micrograms per liter or parts per billion (ppb) 

LOQ - limit of quantification - 0.100 ug/L 

NA - not analyzed 

I I 

Samples were analyzed by Critical Path Services LLC. Reported results 

represent a single analysis, except for the sample collected on 1/18/16. 

Acceptable precision was obtained and the reported results for 

the sample collected on 1/18/16 represent the average of lab 

duplicate results. 

The NJDEP lab certification number for Critical Path Services LLC is PA072. 

Page 1 of 1 

Copy of cwk 662 grab results_jan16.xls:Sheet1 

2/12/2016 2:17 PM
United States Court of Appeals

FOR THE DISTRICT OF COLUMBIA CIRCUIT

____________

No. 20-1038 September Term, 2020

FLRA-0-PS-34

FLRA-85FR41169

Filed On: April 7, 2021 [1893568]

National Treasury Employees Union, 

 Petitioner

v.

Federal Labor Relations Authority, 

 Respondent

------------------------------

Consolidated with 20-1041, 20-1063,

20-1237, 20-1250, 20-1263

BEFORE: Srinivasan, Chief Judge; Rao, Circuit Judge; and Silberman, Senior

Circuit Judge

O R D E R

Upon consideration of petitioners’ unopposed motion for voluntary dismissal, it is

ORDERED that the motion be granted, and these consolidated petitions are

hereby dismissed.

The Clerk is directed to issue the mandate forthwith.

Per Curiam

FOR THE COURT:

Mark J. Langer, Clerk

BY: /s/

Michael C. McGrail

Deputy Clerk

USCA Case #20-1038 Document #1893568 Filed: 04/07/2021 Page 1 of 1
CASE STUDIES IN EMERGENCY ELECTION LITIGATION

Federal Judicial Center 6/14/2023 1

Redistricting Elbert County 

Brown v. Elbert County 

(Hugh Lawson, M.D. Ga. 3:02-cv-45) 

In May 2002, voters filed an action in federal court to have the district lines for two county boards redrawn to reflect the 2000 census. 

The district judge appointed the state reapportionment office to assist him in ordering new district lines and awarded the plaintiffs attorney fees. 

Subject: District lines. Topics: Malapportionment; attorney fees. 

Four voters filed a federal action in the Middle District of Georgia on May 

17, 2002, complaining that the district lines for the boards of commissioners 

and education in Elbert County had not been redrawn to reflect the results of 

the 2000 census.1 The plaintiffs sought a temporary restraining order, among 

other relief.2

Judge Hugh Lawson held a hearing on May 31, and the parties agreed to 

his appointing the director of Georgia’s reapportionment office as an expert 

to assist the court in drawing new district lines.3 On June 4, Judge Lawson 

adopted new district lines.4 The parties agreed to an award to the plaintiffs of 

$8,000 in attorney fees and expenses.5

1. Complaint, Brown v. Elbert County, No. 3:02-cv-45 (M.D. Ga. May 17, 2002), D.E. 1. 

2. Docket Sheet, id. (May 17, 2002). 

3. Redistricting Order, id. (June 4, 2002), D.E. 15; Consent Order, id. (May 31, 2002), 

D.E. 14; Minutes, id. (May 31, 2002), D.E. 13. 

4. Redistricting Opinion, id. (June 12, 2002), D.E. 19; Redistricting Order, supra note 3. 

5. Consent Order, Brown, No. 3:02-cv-45 (M.D. Ga. July 18, 2002), D.E. 21.
[PUBLISH]

IN THE UNITED STATES COURT OF APPEALS
FOR THE ELEVENTH CIRCUIT

________________________ No. 15

- 12816

________________________ D.C. Docket No. 9:13

- cv - 80831

- KAM

ALTMAN CONTRACTORS, INC., a Florida corporation, Plaintiff

- Appellant,

versus CRUM & FORSTER SPECIALTY INSURANCE COMPANY, an Arizona company, Defendant

- Appellee.

________________________ Appeal from the United States District Court for the Southern District of Florida

________________________ (January 26, 2018) Before JORDAN and FAY, Circuit Judges, and FRIEDMAN, * District Judge.

* The Honorable Paul L. Friedman, United States District Judge for the District of Columbia, sitting by designation.

Case: 15-12816 Date Filed: 01/26/2018 Page: 1 of 32 PER CURIAM: This case re turns to us after our certification of a dispositive question of state law to the Florida Supreme Court . For background, we refer the reader to our previous opinion in this case, Altman Contractors, Inc. v. Crum & Forster Specialty Ins. Co. , 832 F.3d 1318 (11th Cir. 2016). In that opinion, we certified the following question : Is the notice and repair process set forth in Chapter 558 of the Florida Statutes a “suit” within the meaning of the CGL policies issued by C&F to ACI? Id . at 1326. The Florida Sup reme Court answered this question in the affirmative, explaining that “[a]lthough the chapter 558 process does not constitute a ‘civil proceeding,’ it is included in the policy’s definition of ‘suit’ as an ‘alternative dispute resolution proceeding’ to whi ch the insurer’s consent is required to invoke the insurer’s duty to defend the insured.” Altman Contractors, Inc. v. Crum & Forster Specialty Ins. Co. , --- So. 3d

--- , No. SC16

- 1420, 2017 WL 6379535, at *5 (Fla. Dec. 14, 2017). The Florida Supreme Court did “not address whether, in this case, C&F consented to [ACI’s] participation in the chapter 558 process because it [was] outside the scope of the certified question and an issue of fact disputed by the parties.” Id

. The Florida Supreme Court , therefore , reached a different conclusion than did the district court regarding whether chapter 558 constitute s an alternative

Case: 15-12816 Date Filed: 01/26/2018 Page: 2 of 33 dispute resolution proceeding (and accordingly a “suit” under the CGL policies at issue)

. Compare id. with Altman Contractors , 832 F.3d a t 1325 (explaining district court’s holding that chapter 558 i s not an alternative dispute resolution proceeding and, therefore, not a ‘suit’ under th e CGL policies). Because “state courts are the ultimate expositors of state law , ” Reaves v. Sec’y, Fla

. Dept. of Corr. , 717 F.3d 886, 903 (11th Cir. 2013), the Florida Supreme Court’s determination on this point is dispositive. Given the benefit of this answer to our certified question, we reverse the grant of summary judgment in favor of C&F , vacate the f inal judgment, and remand this case to the district court for further proceedings. We thank the Florida Supreme Court for accepting, and answering, the certified question. REVERSED , VACATED AND REMANDED. Case: 15-12816 Date Filed: 01/26/2018 Page: 3 of 3
Exhibit 32.1

    CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
                 SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


         In connection with the Quarterly Report of Elite Pharmaceuticals,  Inc.
(the  "Company") on Form 10-Q for the quarter ended June 30, 2007 filed with the
Securities  and Exchange  Commission  (the  "Report"),  I, Bernard  Berk,  Chief
Executive Officer of the Company,  certify, pursuant to 18 U.S. C. Section 1350,
as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

         (1) The Report fully complies with the  requirements  of Section 13(a)
         of the Securities Exchange Act of 1934; and

         (2) The information  contained in the Report fairly  presents,  in all
         material respects, the consolidated financial condition of the Company
         as of the dates presented and the consolidated result of operations of
         the Company for the periods presented.


                                            /s/ Bernard Berk
Date:    August 10, 2007                    ____________________________________
                                            Bernard Berk
                                            Chief Executive Officer of
                                            Elite Pharmaceuticals, Inc.


This  certification  has been  furnished  solely  pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002.

A signed  original of this  written  statement  required by Section 906 has been
provided  to  Elite  Pharmaceuticals,   Inc.  and  will  be  retained  by  Elite
Pharmaceuticals, Inc. and furnished to the Securities and Exchange Commission or
its staff upon request.
EXHIBIT 31.1
------------




              CERTIFICATION PURSUANT TO RULE 13-A-14 AND 15D-14 OF
                     THE SECURITIES AND EXCHANGE ACT OF 1934

I, James Farinella, certify that:

I have reviewed this annual report on Form 10-KSB of T & G2, Inc.

Based in my knowledge, the annual report does not contain any untrue statement
of a material fact or omit to state a material fact necessary to make the
statements made, in light of the circumstances under which such statements were
made, not misleading with respect to the period covered by the annual report.

Based on my knowledge, the financial statements and other financial information
included in the annual report, fairly present in all material respects the
financial condition, results of operations and cash flows of the registrant as
of, and for, the periods presented in this annual report:

The registrant's other certifying officers and I are responsible for
establishing and maintaining disclosure controls and procedures (as defined in
the Exchange Act Rules 13a-14 and 15d-14) for the registrant and have:

Designed such discloser controls and procedures to ensure that material
information relating to the registrant, including its consolidated subsidiaries,
is made known to us by others within those entities, particularly during the
period in which this annual report is being prepared.

Evaluated the effectiveness the registrant's discloser controls and procedures
as of a date within 90 days prior to the filing date of this annual report (the
"Evaluation Date"); and

Presented in this annual report our conclusions about the effectiveness of the
disclosure controls and procedures based on our evaluation as of the evaluation
date.

The registrant's other certifying officers and I have disclosed, based on our
most recent evaluation, to the registrant's auditors and the audit committee of
registrant's board of directors (or persons performing the equivalent
functions):

All significant deficiencies in the design or operation of internal controls
which could adversely affect the registrant's ability to record, process,
summarize and report financial data and have identified for the registrant's
auditors any material weaknesses in internal controls; and

Any fraud, whether or not material, that involves management or other employees
who have a significant role in the registrant's internal controls; and

The registrant's other certifying officers and I have indicated in the this
annual report whether there were significant changes in internal controls or in
other factors that could significantly affect internal controls subsequent to
the date of our most recent evaluation, including any corrective actions with
regard to significant deficiencies and material weaknesses.


Dated: March 30, 2004



                                          /s/ James Farinella
                                         -------------------------------------
                                         James Farinella
                                         President, Chief Executive Officer and
                                         Chief Financial Officer
IN THE DISTRICT COURT OF APPEAL OF THE STATE OF FLORIDA

FIFTH DISTRICT

NOT FINAL UNTIL TIME EXPIRES TO

FILE MOTION FOR REHEARING AND

DISPOSITION THEREOF IF FILED

IRESHA CARN,

Appellant,

v. Case No. 5D22-2101

LT Case No. 2022-300857-CFDB

STATE OF FLORIDA,

Appellee.

________________________________/

Decision filed January 10, 2023

Appeal from the Circuit Court 

for Volusia County,

Karen A. Foxman, Judge.

Matthew J. Metz, Public Defender, and 

Steven N. Gosney, Assistant Public 

Defender, Daytona Beach, for Appellant.

Ashley Moody, Attorney General, 

Tallahassee, and Deborah A. Chance, 

Assistant Attorney General, Daytona 

Beach, for Appellee.

PER CURIAM.

AFFIRMED.

EDWARDS, EISNAUGLE and HARRIS, JJ., concur.